Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models

MLA

Andrea Bertotti, et al. “Combined Blockade of MEK and PI3KCA as an Effective Antitumor Strategy in HER2 Gene Amplified Human Colorectal Cancer Models.” Journal of Experimental & Clinical Cancer Research, vol. 38, June 2019. EBSCOhost, https://doi.org/10.1186/s13046-019-1230-z.

APA

Andrea Bertotti, Davide Ciardiello, Nunzia Matrone, Valentina Belli, Floriana Morgillo, Vincenzo De Falco, Erika Martinelli, Emilio Francesco Giunta, Fortunato Ciardiello, Livio Trusolino, Stefania Napolitano, Umberto Bracale, Giorgia Migliardi, Francesca Cottino, & Teresa Troiani. (2019). Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models. Journal of Experimental & Clinical Cancer Research, 38. https://doi.org/10.1186/s13046-019-1230-z

Chicago

Andrea Bertotti, Davide Ciardiello, Nunzia Matrone, Valentina Belli, Floriana Morgillo, Vincenzo De Falco, Erika Martinelli, et al. 2019. “Combined Blockade of MEK and PI3KCA as an Effective Antitumor Strategy in HER2 Gene Amplified Human Colorectal Cancer Models.” Journal of Experimental & Clinical Cancer Research 38 (June). doi:10.1186/s13046-019-1230-z.